Metabolic Glycoengineering in hMSC-TERT as a Model for Skeletal Precursors by Using Modified Azide/Alkyne Monosaccharides
Metabolic glycoengineering enables a directed modification of cell surfaces by introducing target molecules to surface proteins displaying new features. Biochemical pathways involving glycans differ in dependence on the cell type; therefore, this technique should be tailored for the best results. We...
Main Authors: | , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-03-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/22/6/2820 |
id |
doaj-c7107bc9232a49d9a2c20804bfba11c3 |
---|---|
record_format |
Article |
spelling |
doaj-c7107bc9232a49d9a2c20804bfba11c32021-03-11T00:06:39ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672021-03-01222820282010.3390/ijms22062820Metabolic Glycoengineering in hMSC-TERT as a Model for Skeletal Precursors by Using Modified Azide/Alkyne MonosaccharidesStephan Altmann0Jürgen Mut1Natalia Wolf2Jutta Meißner-Weigl3Maximilian Rudert4Franz Jakob5Marcus Gutmann6Tessa Lühmann7Jürgen Seibel8Regina Ebert9Bernhard-Heine-Center for Locomotion Research, University of Würzburg, Friedrich-Bergius-Ring 15, 97076 Würzburg, GermanyInstitute of Organic Chemistry, University of Würzburg, Am Hubland, 97074 Würzburg, GermanyInstitute of Organic Chemistry, University of Würzburg, Am Hubland, 97074 Würzburg, GermanyBernhard-Heine-Center for Locomotion Research, University of Würzburg, Friedrich-Bergius-Ring 15, 97076 Würzburg, GermanyBernhard-Heine-Center for Locomotion Research, University of Würzburg, Friedrich-Bergius-Ring 15, 97076 Würzburg, GermanyBernhard-Heine-Center for Locomotion Research, University of Würzburg, Friedrich-Bergius-Ring 15, 97076 Würzburg, GermanyInstitute of Pharmacy and Food Chemistry, University of Würzburg, Am Hubland, 97074 Würzburg, GermanyInstitute of Pharmacy and Food Chemistry, University of Würzburg, Am Hubland, 97074 Würzburg, GermanyInstitute of Organic Chemistry, University of Würzburg, Am Hubland, 97074 Würzburg, GermanyBernhard-Heine-Center for Locomotion Research, University of Würzburg, Friedrich-Bergius-Ring 15, 97076 Würzburg, GermanyMetabolic glycoengineering enables a directed modification of cell surfaces by introducing target molecules to surface proteins displaying new features. Biochemical pathways involving glycans differ in dependence on the cell type; therefore, this technique should be tailored for the best results. We characterized metabolic glycoengineering in telomerase-immortalized human mesenchymal stromal cells (hMSC‑TERT) as a model for primary hMSC, to investigate its applicability in TERT-modified cell lines. The metabolic incorporation of <i>N</i>‑azidoacetylmannosamine (Ac<sub>4</sub>ManNAz) and <i>N</i>‑alkyneacetylmannosamine (Ac<sub>4</sub>ManNAl) into the glycocalyx as a first step in the glycoengineering process revealed no adverse effects on cell viability or gene expression, and the in vitro multipotency (osteogenic and adipogenic differentiation potential) was maintained under these adapted culture conditions. In the second step, glycoengineered cells were modified with fluorescent dyes using Cu-mediated click chemistry. In these analyses, the two mannose derivatives showed superior incorporation efficiencies compared to glucose and galactose isomers. In time-dependent experiments, the incorporation of Ac<sub>4</sub>ManNAz was detectable for up to six days while Ac<sub>4</sub>ManNAl-derived metabolites were absent after two days. Taken together, these findings demonstrate the successful metabolic glycoengineering of immortalized hMSC resulting in transient cell surface modifications, and thus present a useful model to address different scientific questions regarding glycosylation processes in skeletal precursors.https://www.mdpi.com/1422-0067/22/6/2820hMSC-TERTmetabolic glycoengineeringglycocalyxmodified monosaccharidesclick chemistry |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Stephan Altmann Jürgen Mut Natalia Wolf Jutta Meißner-Weigl Maximilian Rudert Franz Jakob Marcus Gutmann Tessa Lühmann Jürgen Seibel Regina Ebert |
spellingShingle |
Stephan Altmann Jürgen Mut Natalia Wolf Jutta Meißner-Weigl Maximilian Rudert Franz Jakob Marcus Gutmann Tessa Lühmann Jürgen Seibel Regina Ebert Metabolic Glycoengineering in hMSC-TERT as a Model for Skeletal Precursors by Using Modified Azide/Alkyne Monosaccharides International Journal of Molecular Sciences hMSC-TERT metabolic glycoengineering glycocalyx modified monosaccharides click chemistry |
author_facet |
Stephan Altmann Jürgen Mut Natalia Wolf Jutta Meißner-Weigl Maximilian Rudert Franz Jakob Marcus Gutmann Tessa Lühmann Jürgen Seibel Regina Ebert |
author_sort |
Stephan Altmann |
title |
Metabolic Glycoengineering in hMSC-TERT as a Model for Skeletal Precursors by Using Modified Azide/Alkyne Monosaccharides |
title_short |
Metabolic Glycoengineering in hMSC-TERT as a Model for Skeletal Precursors by Using Modified Azide/Alkyne Monosaccharides |
title_full |
Metabolic Glycoengineering in hMSC-TERT as a Model for Skeletal Precursors by Using Modified Azide/Alkyne Monosaccharides |
title_fullStr |
Metabolic Glycoengineering in hMSC-TERT as a Model for Skeletal Precursors by Using Modified Azide/Alkyne Monosaccharides |
title_full_unstemmed |
Metabolic Glycoengineering in hMSC-TERT as a Model for Skeletal Precursors by Using Modified Azide/Alkyne Monosaccharides |
title_sort |
metabolic glycoengineering in hmsc-tert as a model for skeletal precursors by using modified azide/alkyne monosaccharides |
publisher |
MDPI AG |
series |
International Journal of Molecular Sciences |
issn |
1661-6596 1422-0067 |
publishDate |
2021-03-01 |
description |
Metabolic glycoengineering enables a directed modification of cell surfaces by introducing target molecules to surface proteins displaying new features. Biochemical pathways involving glycans differ in dependence on the cell type; therefore, this technique should be tailored for the best results. We characterized metabolic glycoengineering in telomerase-immortalized human mesenchymal stromal cells (hMSC‑TERT) as a model for primary hMSC, to investigate its applicability in TERT-modified cell lines. The metabolic incorporation of <i>N</i>‑azidoacetylmannosamine (Ac<sub>4</sub>ManNAz) and <i>N</i>‑alkyneacetylmannosamine (Ac<sub>4</sub>ManNAl) into the glycocalyx as a first step in the glycoengineering process revealed no adverse effects on cell viability or gene expression, and the in vitro multipotency (osteogenic and adipogenic differentiation potential) was maintained under these adapted culture conditions. In the second step, glycoengineered cells were modified with fluorescent dyes using Cu-mediated click chemistry. In these analyses, the two mannose derivatives showed superior incorporation efficiencies compared to glucose and galactose isomers. In time-dependent experiments, the incorporation of Ac<sub>4</sub>ManNAz was detectable for up to six days while Ac<sub>4</sub>ManNAl-derived metabolites were absent after two days. Taken together, these findings demonstrate the successful metabolic glycoengineering of immortalized hMSC resulting in transient cell surface modifications, and thus present a useful model to address different scientific questions regarding glycosylation processes in skeletal precursors. |
topic |
hMSC-TERT metabolic glycoengineering glycocalyx modified monosaccharides click chemistry |
url |
https://www.mdpi.com/1422-0067/22/6/2820 |
work_keys_str_mv |
AT stephanaltmann metabolicglycoengineeringinhmsctertasamodelforskeletalprecursorsbyusingmodifiedazidealkynemonosaccharides AT jurgenmut metabolicglycoengineeringinhmsctertasamodelforskeletalprecursorsbyusingmodifiedazidealkynemonosaccharides AT nataliawolf metabolicglycoengineeringinhmsctertasamodelforskeletalprecursorsbyusingmodifiedazidealkynemonosaccharides AT juttameißnerweigl metabolicglycoengineeringinhmsctertasamodelforskeletalprecursorsbyusingmodifiedazidealkynemonosaccharides AT maximilianrudert metabolicglycoengineeringinhmsctertasamodelforskeletalprecursorsbyusingmodifiedazidealkynemonosaccharides AT franzjakob metabolicglycoengineeringinhmsctertasamodelforskeletalprecursorsbyusingmodifiedazidealkynemonosaccharides AT marcusgutmann metabolicglycoengineeringinhmsctertasamodelforskeletalprecursorsbyusingmodifiedazidealkynemonosaccharides AT tessaluhmann metabolicglycoengineeringinhmsctertasamodelforskeletalprecursorsbyusingmodifiedazidealkynemonosaccharides AT jurgenseibel metabolicglycoengineeringinhmsctertasamodelforskeletalprecursorsbyusingmodifiedazidealkynemonosaccharides AT reginaebert metabolicglycoengineeringinhmsctertasamodelforskeletalprecursorsbyusingmodifiedazidealkynemonosaccharides |
_version_ |
1724226164908621824 |